Pfizer Inc
SGO:PFE
Pfizer Inc
SGO:PFE
Price:
49.19
USD
-0.36%
Market Closed
Market Cap:
$165.2B
Relative Value
The Relative Value of one
PFE
stock under the Base Case scenario is
64.34
USD.
Compared to the current market price of 49.19 USD,
Pfizer Inc
is
Undervalued by 24%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PFE
Relative Value
Base Case
64.34
USD
Undervaluation 24%
Multiples Across Competitors
PFE Competitors Multiples
Pfizer Inc Competitors
Pfizer Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Pfizer Inc
SGO:PFE
|
153.4B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
994.4B USD | 15.3 | 48.2 | 32.5 | 34.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.7B GBP | 5.1 | 31.7 | 15.1 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.1B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.8 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.5 | 6.9 | 8.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
103.1B EUR | 2.7 | 15.7 | 7.9 | 11.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
